AcouSort AB (publ) (STO:ACOU)
2.870
-0.110 (-3.69%)
Sep 24, 2026, 4:59 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 63.07 million as of September 24, 2026. Its market cap has decreased by -10.78% in one year.
Market Cap
63.07M
Enterprise Value
53.59M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.87
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has decreased from 65.36M to 63.07M, a decrease of -3.50%. That is a compound annual growth rate of -0.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 63.07M | 5.30% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 107.95M |
| Nanologica AB | 101.92M |
| Biovica International AB | 92.24M |
| Pila Pharma AB | 85.43M |
| Ascelia Pharma AB | 82.79M |
| Alzinova AB | 81.46M |
| Spago Nanomedical AB | 78.08M |
| Annexin Pharmaceuticals AB | 71.30M |